Assessment and management of ulcerative colitis in children

A Ferguson1

  • 1Department of Medicine, Western General Hospital and University of Edinburgh, UK.

Insights

Pediatric ulcerative colitis (UC) presents differently than in adults, often with more extensive disease. Despite challenges in pediatric clinical trials, management focuses on nutrition, growth, and psychological well-being, with good long-term outcomes for most patients.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Clinical Pediatrics

Background:

  • Ulcerative colitis (UC) incidence in European school-age children remains stable at 1.5-2.0 per 100,000 annually.
  • Pediatric UC often presents with abdominal pain, rectal bleeding, or diarrhea, and typically involves more extensive disease compared to adults.
  • Clinical trials for pediatric UC therapies are notably scarce, hindering evidence-based treatment advancements.

Purpose of the Study:

  • To review the clinical presentation and management principles of ulcerative colitis in children.
  • To highlight the challenges and limitations in conducting clinical trials for pediatric UC.
  • To present long-term health status data for young adults diagnosed with childhood-onset UC.

Main Methods:

  • Review of existing literature on pediatric ulcerative colitis incidence, presentation, and management.
  • Discussion of the limitations of subjective disease severity indices in children.
  • Emphasis on objective measures like endoscopy and gut protein loss tests for disease assessment.

Main Results:

  • Pediatric UC exhibits a more extensive disease distribution compared to adult cases.
  • Subjective assessments of disease activity are unreliable in children, necessitating objective measures.
  • Young adults with childhood-onset UC generally report good health status, with a majority feeling fully fit.

Conclusions:

  • Effective management of pediatric ulcerative colitis requires meticulous attention to nutrition, growth, and psychological factors alongside standard medical treatments.
  • Objective diagnostic tools are crucial for accurate assessment of disease extent and activity in pediatric UC.
  • Despite challenges, childhood-onset ulcerative colitis can have a favorable long-term prognosis for many individuals.

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...